The monkeypox virus is only one mutation away from avoiding a major antiviral drug used to treat at-risk individuals, according to federal health experts, who are advising doctors to be “judicious” in administering the desired treatment. The new FDA guidance for the antiviral medicine tecovirimat, or Tpoxx, was released online...